Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
34

FOLD
Amicus Therapeutics

Last Price:
9.87
Seasonality Move:
7.75%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
253.02
Seasonality Move:
7.55%
Sell
34
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.87. The Score for FOLD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $253.35. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $253.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 38.25 Sell
Chaikin Money Flow: 826536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.87 - 11.53) Sell
Bollinger Bands (100): (10.16 - 11.54) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.33 Sell
Relative Strength Index (14 RSI): 44.29 Sell
Chaikin Money Flow: 851531 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (247.71 - 283.73) Sell
Bollinger Bands (100): (248.8 - 281.72) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.65 Buy
20-day SMA: 10.48 Sell
50-day SMA: 10.75 Sell
200-day SMA: 10.94 Sell
8-day EMA: 9.82 Buy
20-day EMA: 10.25 Sell
50-day EMA: 10.64 Sell
200-day EMA: 10.98 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 243.36 Buy
20-day SMA: 259.9 Sell
50-day SMA: 271.86 Sell
200-day SMA: 212.45 Buy
8-day EMA: 249.92 Buy
20-day EMA: 258.06 Sell
50-day EMA: 264.29 Sell
200-day EMA: 231.45 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):